SynAbs inks agreement with Theranostica as new distributor for its unique catalogue of monoclonal antibodies in Israël

SynAbs is proud to announce strategic deal with successful company Theranostica. Theranostica already distributes major references in the field of monoclonal antibodies and will consequently extends its catalogue with unique mAbs references from SynAbs. Under the terms of the agreement, Theranostica will have access to unique portfolio of rats and guinea pigs mAbs to address Israël territories needs in R&D and IVD fields.